Cidara Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
San Diego, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Cidara Therapeutics, Inc. has filed 798 SEC EDGAR filings since 17 Jun 2014

SEC filing history

Showing 176-200 of 798 matching filings.

Per page
25
Current page
8
10-Q File 001-36912

CIDARA THERAPEUTICS, INC. FORM 10-Q

Filing date
13 Aug 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
EFFECT File 333-280919

EFFECT filing

Filing date
31 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-280919

424B3

Filing date
31 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88806

SC 13G

Filing date
29 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88806

SC 13G

Filing date
29 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
29 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-280919

UPLOAD filing

Filing date
29 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D File 005-88806

SC 13D

Filing date
25 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
22 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

4/A filing

Filing date
22 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
19 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-280919

S-1

Filing date
19 Jul 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
19 Jul 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36912

CIDARA THERAPEUTICS, INC. FORM 8-K

Filing date
18 Jul 2024
Reporting date
18 Jul 2024
Next action
Verify source filing
4

FORM 4

Filing date
11 Jun 2024
Reporting date
07 Jun 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
ARS File 001-36912

ARS

Filing date
03 Jun 2024
Reporting date
31 Dec 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-36912

DEFINITIVE ADDITIONAL MATERIALS

Filing date
03 Jun 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-36912

DEFINITIVE PROXY STATEMENT

Filing date
03 Jun 2024
Reporting date
18 Jul 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .